Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonics West Showcase
Menu
Historical Archive

Business briefs

17 Jun 2002

Including news from Bookham Technology, Coherent, Three-Five Systems, Lasos Lasertechnik and more.

  • UK-based Bookham Technology, a provider of integrated optical components, has posted first quarter revenues of EURO 9 million (USD 8 million), a 169% sequential rise from the previous quarter but down 52% year-on-year. The results include those of Marconi's optical components business which Bookham acquired on February 1 this year.

  • US-based Three-Five Systems has acquired all the patents and selected assets from fellow US displays developer Inviso. Three-Five's president Jack Saltich said: "With the addition of Inviso intellectual property, we are able to expand our microdisplay optics capabilities. We now possess optics designs that can be utilized in near-to-eye microdisplay-based products."

  • Coherent, US, has announced second quarter sales of USD 98.6 million, a USD 2 million increase from the previous quarter but down 24% year-on-year. The company also posted 19% decrease in year-to-date sales of USD 195.3 million.

  • Lasos Lasertechnik of Germany and US-based National Laser have combined their resources to jointly market their ion, helium-neon and solid-state lasers. Lasos will promote both companies' products in Europe whilst National Laser will focus on selling to the North and South American markets.

  • Teem Photonics of France, a provider of ultra-compact solutions for optical networks, is to open a US subsidiary based in New York City. The company hopes to establish a greater US presence and bring its products closer to its predominant customer-base.

  • PLC Systems, a US-based developer of carbon-dioxide laser technology for treating angina, has reported stable quarterly revenues of USD 2.4 million. Company president Mark Tauscher said: "We believe the 35% increase in our laser base over the past 12 months emphasizes the significant demand for CO2 revascularization therapy."

  • AlluxaBerkeley Nucleonics CorporationHyperion OpticsCeNing Optics Co LtdSPECTROGON ABHÜBNER PhotonicsIridian Spectral Technologies
    © 2024 SPIE Europe
    Top of Page